202 related articles for article (PubMed ID: 22336946)
1. siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.
Pendaries V; Gasc G; Titeux M; Tonasso L; Mejía JE; Hovnanian A
J Invest Dermatol; 2012 Jun; 132(6):1741-3. PubMed ID: 22336946
[No Abstract] [Full Text] [Related]
2. A mutation-independent therapeutic strategy for dominant dystrophic epidermolysis bullosa.
Morgan CP; Allen DSI; Millington-Ward S; O'Dwyer GE; Palfi A; Jane Farrar G
J Invest Dermatol; 2013 Dec; 133(12):2793-2796. PubMed ID: 23743647
[No Abstract] [Full Text] [Related]
3. Gene therapy for recessive dystrophic epidermolysis bullosa.
Titeux M; Pendaries V; Hovnanian A
Dermatol Clin; 2010 Apr; 28(2):361-6, xii. PubMed ID: 20447504
[TBL] [Abstract][Full Text] [Related]
4. A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa.
Cutlar L; Zhou D; Hu X; Duarte B; Greiser U; Larcher F; Wang W
Exp Dermatol; 2016 Oct; 25(10):818-20. PubMed ID: 27117059
[No Abstract] [Full Text] [Related]
5. Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.
Woodley DT; Chen M
J Invest Dermatol; 2015 Jul; 135(7):1705-1707. PubMed ID: 26066885
[No Abstract] [Full Text] [Related]
6. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
7. Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo.
Woodley DT; Keene DR; Atha T; Huang Y; Ram R; Kasahara N; Chen M
Mol Ther; 2004 Aug; 10(2):318-26. PubMed ID: 15294178
[TBL] [Abstract][Full Text] [Related]
8. EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.
Gaucher S; Lwin SM; Titeux M; Abdul-Wahab A; Pironon N; Izmiryan A; Miskinyte S; Ganier C; Duchatelet S; Mellerio JE; Bourrat E; McGrath JA; Hovnanian A
Br J Dermatol; 2020 Mar; 182(3):794-797. PubMed ID: 31557321
[No Abstract] [Full Text] [Related]
9. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa.
Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW
J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561
[TBL] [Abstract][Full Text] [Related]
10. A Japanese case of de novo dominant dystrophic epidermolysis bullosa.
Matsuba S; Suga Y; Mayuzumi N; Ikeda S; Ogawa H
Clin Exp Dermatol; 2002 Jan; 27(1):56-8. PubMed ID: 11952672
[TBL] [Abstract][Full Text] [Related]
11. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
Perdoni C; Osborn MJ; Tolar J
Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
[TBL] [Abstract][Full Text] [Related]
12. Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.
Tovar Vetencourt A; Sayed-Ahmed I; Gomez J; Chen H; Agostini B; Carroll K; Parry T; Krishnan S; Sabater AL
N Engl J Med; 2024 Feb; 390(6):530-535. PubMed ID: 38324486
[TBL] [Abstract][Full Text] [Related]
13. Localised Dominant Dystrophic Epidermolysis Bullosa with a Novel de Novo Mutation in COL7A1 Diagnosed by Next-generation Sequencing.
Nagai M; Nagai H; Tominaga C; Sakaguchi Y; Jitsukawa O; Ohgo N; Nishigori C; Yamanishi K
Acta Derm Venereol; 2015 May; 95(5):629-31. PubMed ID: 25425313
[No Abstract] [Full Text] [Related]
14. Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.
Almaani N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Wong A; Nanda A; Moss C; Martinéz AE; Mellerio JE; McGrath JA
Acta Derm Venereol; 2011 May; 91(3):262-6. PubMed ID: 21448560
[TBL] [Abstract][Full Text] [Related]
15. An RNA-targeted therapy for dystrophic epidermolysis bullosa.
Peking P; Koller U; Duarte B; Murillas R; Wolf S; Maetzig T; Rothe M; Kocher T; García M; Brachtl G; Schambach A; Larcher F; Reichelt J; Bauer JW; Murauer EM
Nucleic Acids Res; 2017 Sep; 45(17):10259-10269. PubMed ID: 28973459
[TBL] [Abstract][Full Text] [Related]
16. Inversa dystrophic epidermolysis bullosa is caused by missense mutations at specific positions of the collagenic domain of collagen type VII.
Chiaverini C; Charlesworth AV; Youssef M; Cuny JF; Rabia SH; Lacour JP; Meneguzzi G
J Invest Dermatol; 2010 Oct; 130(10):2508-11. PubMed ID: 20555349
[No Abstract] [Full Text] [Related]
17. A biologic Velcro patch.
Tolar J; Wagner JE
N Engl J Med; 2015 Jan; 372(4):382-4. PubMed ID: 25607432
[No Abstract] [Full Text] [Related]
18. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
[TBL] [Abstract][Full Text] [Related]
19. Dystrophic epidermolysis bullosa with one dominant and one recessive mutation of the COL7A1 gene in a child with deafness.
Weinel S; Lucky AW; Uitto J; Pfendner EG; Choo D
Pediatr Dermatol; 2008; 25(2):210-4. PubMed ID: 18429782
[TBL] [Abstract][Full Text] [Related]
20. Epidermolysis Bullosa Acquisita Develops in Dominant Dystrophic Epidermolysis Bullosa.
Hayashi R; Natsuga K; Watanabe M; Iwata H; Shinkuma S; Ito A; Masui Y; Ito M; Shimomura Y
J Invest Dermatol; 2016 Jan; 136(1):320-3. PubMed ID: 26763454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
